MedTrace Logo

Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches

NCT01740219 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 348

Last updated 2019-06-20

No results posted yet for this study

Summary

This research study aims to develop an organizational-level intervention to enable communities to adopt, adapt, implement and sustain evidence-based interventions (EBIs) to address cancer disparities among Latinos. The investigators partner with faith-based organizations, since they play a highly prominent role in Latino community life. This three-phase study will: (1) improve understanding of the organizational infrastructure, skills and resources required by Latino churches to implement EBIs for cancer control, (2) develop a capacity-building intervention; and (3) test the intervention's effectiveness in a randomized trial.

Conditions

Interventions

BEHAVIORAL

Capacity Enhancement

Churches in the Capacity Enhancement intervention will be invited to work with CRUZA staff over the course of a three month intervention to implement health promotion activities in their church and participate in capacity-building educational workshops. Participants may also receive technical assistance from Health Educators in order to implement their cancer education activities.

BEHAVIORAL

Standard Dissemination

Churches in the Standard Dissemination arm will receive program materials with information about cancer prevention/early detection and health resources.

Sponsors & Collaborators

Principal Investigators

  • Jennifer D Allen, ScD · Dana-Farber Cancer Institute

  • Maria Idali Torres, PhD · University of Massachusetts, Boston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740219 on ClinicalTrials.gov